Do you know the drugs that are hiding in your medical claim costs?
"This is an eye-opener — and we're angry!"
That’s the reaction from some of our clients on learning that specialty drugs are driving up healthcare costs in their medical plan.
With names like Remicade, Gamunex, and Neulasta, they and others will consume half of your entire healthcare budget in the next 10 years. In fact, for some employers, growth has already topped 50%, which will likely be the norm by 2022!
PBMs and employers have deployed strategies to address spend under the pharmacy benefit. But these drugs are being claimed under the medical benefit. Can you afford not to do something about it?
Buck’s pharmacy experts, Gail Levenson and Bob Ferraro, will discuss various tactics available to plan sponsors, including:
-
How to manage your costs through consistent mining of medical and pharmacy claims data
-
How to determine what specialty drug costs are hiding in your medical plan and quantify them
-
How to create a roadmap for managing special drug costs
-
What questions you should be asking your medical plan vendor
-
What strategies are working in managing specialty drugs under your medical benefit
About the speakers
Bob Ferraro, Principal, National Pharmacy Practice
Bob is a pharmacist and Principal in Buck’s National Pharmacy Practice. He has worked with self-funded employers, unions, and trusts for over 20 years to help them procure, design, and manage prescription drug benefits.
Gail Levenson, Principal, National Pharmacy Practice
Gail is a pharmacist and Principal in Buck’s National Pharmacy Practice. She has over 30 years of experience helping employers of all sizes manage their prescription benefits. She has deep clinical expertise and experience working with retiree plans.